Citation: Mj. Landray et al., ASSOCIATION OF ATHEROGENIC LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS WITH CAROTID ATHEROSCLEROSIS, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(5), 1998, pp. 345-351
Authors:
BLANN AD
LYDAKIS C
LANDRAY MJ
SINGH S
WATSON RDS
ZARIFIS J
AMIRAL J
BEEVERS D
LIP GYH
Citation: Ad. Blann et al., ENDOTHELIAL AND PLATELET ACTIVATION FOLLOWING STREPTOKINASE FOR ACUTEMYOCARDIAL-INFARCTION, Journal of vascular research, 35, 1998, pp. 109-109
Citation: Mj. Landray, ETHICS AND INTERNATIONAL RESEARCH - POTENTIAL ENTICEMENT OF PLACEBO TRIALS NEEDS TO BE DEBATED, BMJ. British medical journal, 316(7131), 1998, pp. 626-627
Authors:
LANDRAY MJ
RINGROSE T
FERNER RE
ARNOLD IR
Citation: Mj. Landray et al., PYREXIA, ANEMIA AND ACUTE-RENAL-FAILURE SECONDARY TO OMEPRAZOLE, Postgraduate medical journal, 74(873), 1998, pp. 416-418
Authors:
BLANN AD
LYDAKIS C
LANDRAY MJ
SINGH S
WATSON RDS
ZARIFIS J
AMIRAL J
BEEVERS DG
LIP GYH
Citation: Ad. Blann et al., PLATELET AND ENDOTHELIAL ACTIVATION FOLLOWING STREPTOKINASE FOR ACUTEMYOCARDIAL-INFARCTION, British Journal of Haematology, 101, 1998, pp. 137-137
Citation: Mj. Landray et al., TOTAL ANTIOXIDANT CAPACITY BY ENHANCED CHEMILUMINESCENCE - CONTRIBUTION OF URATE, Annals of clinical biochemistry, 35, 1998, pp. 553-554
Citation: Mj. Landray et Mj. Kendall, BETA-BLOCKERS IN HEART-FAILURE - A CARDIOPROTECTIVE THERAPY, Journal of clinical pharmacy and therapeutics, 22(3), 1997, pp. 181-185
Citation: Mj. Landray et Mj. Kendall, CORONARY-ARTERY DISEASE AND ANTIOXIDANTS - IS THERE A ROLE FOR CARVEDILOL - COMMENTARY, Journal of clinical pharmacy and therapeutics, 22(1), 1997, pp. 3-5